avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nfatc1 | mm10_v2_chr18_-_80713062_80713080 | 0.37 | 2.6e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_+_3023547 Show fit | 7.14 |
ENSMUST00000099046.3
|
predicted gene 10718 |
|
chr9_+_3000922 Show fit | 6.79 |
ENSMUST00000151376.2
|
predicted gene 10722 |
|
chr2_-_98667264 Show fit | 6.50 |
ENSMUST00000099683.1
|
predicted gene 10800 |
|
chr9_+_3027439 Show fit | 6.21 |
ENSMUST00000177875.1
ENSMUST00000179982.1 |
predicted gene 10717 |
|
chr16_-_16863817 Show fit | 6.02 |
ENSMUST00000124890.1
|
immunoglobulin lambda-like polypeptide 1 |
|
chr9_+_3013140 Show fit | 5.88 |
ENSMUST00000143083.2
|
predicted gene 10721 |
|
chr7_-_142679533 Show fit | 5.39 |
ENSMUST00000162317.1
ENSMUST00000125933.1 ENSMUST00000105931.1 ENSMUST00000105930.1 ENSMUST00000105933.1 ENSMUST00000105932.1 ENSMUST00000000220.2 |
insulin II |
|
chr9_+_3017408 Show fit | 4.95 |
ENSMUST00000099049.3
|
predicted gene 10719 |
|
chr9_+_3034599 Show fit | 4.74 |
ENSMUST00000178641.1
|
predicted gene, 17535 |
|
chr19_+_52264323 Show fit | 4.65 |
ENSMUST00000039652.4
|
insulin I |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 6.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.6 | 5.7 | GO:0032264 | IMP salvage(GO:0032264) |
1.8 | 5.4 | GO:1990535 | negative regulation of NAD(P)H oxidase activity(GO:0033861) neuron projection maintenance(GO:1990535) |
0.8 | 4.5 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
1.5 | 4.4 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.0 | 4.1 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
1.1 | 3.3 | GO:2000458 | immune complex clearance by monocytes and macrophages(GO:0002436) astrocyte chemotaxis(GO:0035700) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) negative regulation of eosinophil activation(GO:1902567) positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) regulation of astrocyte chemotaxis(GO:2000458) |
0.7 | 3.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 3.0 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 2.9 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 6.0 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.2 | 5.4 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.3 | 4.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 3.3 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 2.8 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 2.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 2.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 2.6 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 2.5 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 2.5 | GO:0005814 | centriole(GO:0005814) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 6.7 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 6.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.3 | 6.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.6 | 5.7 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.6 | 4.9 | GO:0045159 | myosin II binding(GO:0045159) |
1.5 | 4.5 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.2 | 4.4 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
1.1 | 3.3 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
0.1 | 3.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 2.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 6.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 5.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 3.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 3.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 2.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 2.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 2.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 2.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 2.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 2.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 5.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 5.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 4.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 4.3 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 3.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.6 | 3.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 3.0 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 2.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 2.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 2.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |